Creyon Bio And Lilly Enter Into Rna-Targeted Oligo Therapy Development Collaboration
Eli Lilly and Co LLY.N:
CREYON BIO AND LILLY ENTER INTO RNA-TARGETED OLIGO THERAPY DEVELOPMENT COLLABORATION
CREYON BIO: WILL RECEIVE A $13 MILLION UPFRONT PAYMENT
CREYON BIO: ELIGIBLE TO GET OVER $1 BILLION IN DEVELOPMENT, COMMERCIALIZATION PAYMENTS PROVIDED SOME MILESTONES ACHIEVED
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Why SanDisk Stock Could Soar to $4,000?

US-Iran Tensions Heat Up Again, Brent Crude Prices Return Above $100

AI Chip Sector Adds Heavyweight Player, Nvidia Rival Cerebras Plans to List Next Week, Targeting Largest US IPO of the Year

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

GOOGL Stock: Should You Buy the Best-Performing Magnificent Seven Stock Right Now?

Tradingkey






